Academic Journal

Heterologous expression of interferon-stimulated genes reveals conserved anti- Toxoplasma properties between human and porcine cells.

Bibliographic Details
Title: Heterologous expression of interferon-stimulated genes reveals conserved anti- Toxoplasma properties between human and porcine cells.
Authors: Ungogo, Marzuq A., Chandrasegaran, Praveena R. G., Khalid, Hamza, Powell, Jessica, Jamil, Hamna, Grey, Finn, Hassan, Musa A.
Source: Frontiers in Immunology; 2026, p1-11, 11p
Subject Terms: Toxoplasma, Interferon gamma, Animal cell biotechnology, Indoleamine 2,3-dioxygenase, Gene expression, Interferon inducers, Interferon regulatory factors, Somatic cells
Abstract: Toxoplasma is a zoonotic parasite that can cause life-threatening illness in humans and animals. The similarities in Toxoplasma pathogenesis between pigs and humans make pigs an attractive model for studying human toxoplasmosis. However, the mechanisms underpinning these similarities remain poorly understood. Since interferon-gamma (IFNγ) is crucial for immunity to Toxoplasma , we hypothesized that IFNγ signaling pathways conserved between humans and pigs contribute to comparable Toxoplasma pathogenesis. Using a genetic gain-of-function strategy, we observed that human or porcine interferon regulatory factor 1 (IRF1) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibited Toxoplasma replication in both homologous and heterologous human and porcine cells. IRF1-depleted porcine cells that failed to control Toxoplasma growth could be rescued by ectopic expression of human IRF1, which induces genes similar to those regulated by porcine IRF1. The expression of either human or pig IRF1 dampened Toxoplasma- induced transcriptional remodeling of porcine genes. Additionally, blocking IDO1 using 1-methyl tryptophan reversed parasite growth inhibition in cells expressing heterologous or homologous IDO1. These findings highlight conserved IFN-induced anti- Toxoplasma mechanisms between pigs and humans and enhance the potential of pigs as large animal models for human toxoplasmosis. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Description
ISSN:16643224
DOI:10.3389/fimmu.2026.1790284